UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File No.
0-12258
CUSIP No.
163611-304
Form 10-K Form 20-F Form 11-K X Form 10-Q Form N-SAR
For Period Ended: November 30, 1997
PART I - REGISTRANT INFORMATION
Chemfix Technologies, Inc.
Full Name of Registrant
Former Name if Applicable
3500 N. Causeway Blvd., Suite 1280
Address of Principal Executive Office (Street and Number)
Metairie, LA 70002
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense;
X (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject
quarterly report of transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
Due to serious financial problems, the Registrant's accounting staff
have been terminated which in turn has caused delays in completing
first quarter financials and subsequently a delay in filing the
Registrant's Form 10-Q. Therefore, we are requesting a 30-day
extension.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
David L. Donaldson (504) 831-3600
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(b)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months
(or for such shorter) period that the registrant was required
to file such reports) been filed? If answer is no, identify
report(s).
X Yes No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included
in the subject report or portion thereof?
Yes X No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
Chemfix Technologies, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date January 15, 1998 By
David L. Donaldson, President and CEO
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
